NCT03024047

Brief Summary

Background: Disturbances of the heart's atrioventricular conduction - AV-block - may show by shortness of breath, fainting or sudden death. If AV-block is diagnosed in time pacemaker therapy may be lifesaving. AV-block in younger can be seen along with structural or ischemic heart disease, congenital heart disease (incl. congenital AV-block) storage disorders, specific muscle diseases, sarcoidosis, Borrelia infection or drug intoxication. AV-block in younger can also be seen in conditions, primarily localized to the AV-node without other cardiac disease at diagnosis. This form of AV-block is often hereditary and can be seen in families where relatives have another types of heart disease in form of fore example, cardiomyopathy, ion channel disease or sudden death. The different forms of presentation are due to the same gene mutation being expressed differently within the same family. Thus, early onset of AV-block (\<50 years) may indicate hereditary AV-conduction disorder but it can also be the first manifestation of severe ion channel disease or cardiomyopathy. Denmark has annually over 50 individuals \<50 years treated with pacemaker due to advanced AV-block. There have been no overall figures regarding the causes of advanced AV-block, and therefore no systematic approach to diagnosing this group of patients. Furthermore, the prevalence of individuals with a genetic cause of AV-block is unknown and presumably an often overlooked diagnosis among younger patients with advanced AV-blok. There are no data on disease progression after diagnosis, and therefore there is no evidence-based knowledge about how these patients should be followed after diagnosis. With modern gene technology, a range of new, yet unknown genes with potentially pathogenic mutations is likely to be identified. Identification of such genes, and the development of a strategy for systematic approach to diagnose younger patients with AV-block, will enable presymptomatic genetic screening of relatives and implementation of evidence-based, preventive treatment with pacemaker and/or medical treatment for heart failure based on a specific genetic predisposition for development of AV-block with or without heart failure. Hypotheses: In a significant proportion of younger patients with advanced AV-block the underlying cause is unknown. Objective: To investigate the prevalence and causes of advanced AV-block in younger patients in Denmark and describe the current diagnostics. Method: The study is a cross sectional study. The patients for this study are identified from Danish Pacemaker and ICD Register. The investigators will review medical records and obtain clinical information and test results (see detailed description). Perspectives: This study is the first part of a large study of AV-block in younger patients in Denmark. The overall goal, is to increase knowledge about the causes of and disease progression after the diagnosis of advanced AV-block in young patients which could lead to a significant improvement in the treatment of this patient group and may lead to a customized choice of pacemaker type in the future and perhaps additional medical treatment in this patient group. This could potentially lead to a reduction in both their morbidity mortality.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,255

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

January 4, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 18, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
Last Updated

January 18, 2017

Status Verified

January 1, 2017

Enrollment Period

1.6 years

First QC Date

January 4, 2017

Last Update Submit

January 13, 2017

Conditions

Outcome Measures

Primary Outcomes (12)

  • Prevalence of structural heart disease as cause of AV-block

    01.01.1996 - 31.12.2015

  • Prevalence of ischemic heart disease as cause of AV-block

    01.01.1996 - 31.12.2015

  • Prevalence of congenital heart disease as cause of AV-block

    01.01.1996 - 31.12.2015

  • Prevalence of congenital AV-block

    01.01.1996 - 31.12.2015

  • Prevalence of muscular dystrophy as cause of AV-block

    01.01.1996 - 31.12.2015

  • Prevalence of sarcoidosis as cause of AV-block

    01.01.1996 - 31.12.2015

  • Prevalence of lyme disease as cause of AV-block

    01.01.1996 - 31.12.2015

  • Prevalence of genetic cause of AV-block

    01.01.1996 - 31.12.2015

  • Prevalence of complications to operation as cause of AV-block

    01.01.1996 - 31.12.2015

  • Prevalence of complications to radio frequency ablation as cause of AV-block

    01.01.1996 - 31.12.2015

  • Prevalence of endocarditis as cause of AV-block

    01.01.1996 - 31.12.2015

  • Prevalence of unknown cause of AV-block

    01.01.1996 - 31.12.2015

Interventions

PacemakerDEVICE

Eligibility Criteria

AgeUp to 49 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

All patients in Denmark with AV-block who were treated with pacemaker for the first time between 01.01.1996 - 31.12.2015 with age at implantation \<50 years will be included in the study (n=1,255 patients).

You may qualify if:

  • All patients in Denmark
  • Treated with pacemaker due to AV-block
  • Implanted for the first time between 01.01.1996 - 31.12.2015
  • Age at implantation \<50 years

You may not qualify if:

  • Non

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of cardiology, Research, Aarhus University Hospital, Denmark

Aarhus, 8200, Denmark

Location

MeSH Terms

Conditions

Atrioventricular BlockBundle-Branch BlockGenetic Diseases, Inborn

Condition Hierarchy (Ancestors)

Heart BlockArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and SymptomsCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Johnni T. R. Dideriksen, M.D.

CONTACT

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2017

First Posted

January 18, 2017

Study Start

January 1, 2017

Primary Completion

August 1, 2018

Last Updated

January 18, 2017

Record last verified: 2017-01

Locations